PASG Insider Trading
Insider Ownership Percentage: 4.30%
Insider Buying (Last 12 Months): $408,099.13
Insider Selling (Last 12 Months): $516,689.42
Passage Bio Insider Trading History Chart
This chart shows the insider buying and selling history at Passage Bio by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Passage Bio Share Price & Price History
Current Price: $0.33
Price Change: ▲ Price Increase of +0.001 (0.30%)
As of 04/17/2025 05:00 PM ET
Passage Bio Insider Trading History
Passage Bio Institutional Trading History
Data available starting January 2016
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Read More on Passage Bio
Volume
157,546 shs
Average Volume
331,513 shs
Market Capitalization
$20.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.59
Who are the company insiders with the largest holdings of Passage Bio?
Passage Bio's top insider shareholders include:
- Lynx1 Capital Management Lp (Major Shareholder)
- Orbimed Advisors Llc (Major Shareholder)
- Mark S Forman (Insider)
- Alexandros Fotopoulos (Insider)
- Kathleen Borthwick (CFO)
- Simona King (CFO)
Learn More about top insider investors at Passage Bio.